INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ISRG - US46120E6023 - Common Stock
503.2 EUR
+16.55 (+3.4%)
We assign a fundamental rating of 6 out of 10 to 1ISRG. 1ISRG was compared to 65 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making 1ISRG a very profitable company, without any liquidiy or solvency issues. 1ISRG shows excellent growth, but is valued quite expensive already. These ratings could make 1ISRG a good candidate for growth and quality investing.
1. Profitability
1.1 Basic Checks
In the past year 1ISRG was profitable.
In the past year 1ISRG had a positive cash flow from operations.
In the past 5 years 1ISRG has always been profitable.
1ISRG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1ISRG's Return On Assets of 14.19% is amongst the best of the industry. 1ISRG outperforms 89.23% of its industry peers.
1ISRG has a Return On Equity of 16.12%. This is in the better half of the industry: 1ISRG outperforms 80.00% of its industry peers.
With an excellent Return On Invested Capital value of 12.45%, 1ISRG belongs to the best of the industry, outperforming 87.69% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1ISRG is in line with the industry average of 10.04%.
The last Return On Invested Capital (12.45%) for 1ISRG is above the 3 year average (10.15%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 12.45% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1.3 Margins
1ISRG has a better Profit Margin (28.58%) than 95.38% of its industry peers.
In the last couple of years the Profit Margin of 1ISRG has declined.
1ISRG's Operating Margin of 29.44% is amongst the best of the industry. 1ISRG outperforms 96.92% of its industry peers.
1ISRG's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 66.38%, 1ISRG is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
Compared to 1 year ago, 1ISRG has more shares outstanding
1ISRG has more shares outstanding than it did 5 years ago.
There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.27
WACC9.81%
2.3 Liquidity
1ISRG has a Current Ratio of 4.97. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
1ISRG has a Current ratio of 4.97. This is amongst the best in the industry. 1ISRG outperforms 96.92% of its industry peers.
A Quick Ratio of 4.20 indicates that 1ISRG has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.20, 1ISRG belongs to the best of the industry, outperforming 96.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.12% over the past year.
Measured over the past years, 1ISRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.48% on average per year.
1ISRG shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.18%.
The Revenue has been growing by 13.27% on average over the past years. This is quite good.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
Based on estimates for the next years, 1ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.47% on average per year.
The Revenue is expected to grow by 14.12% on average over the next years. This is quite good.
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1ISRG is valuated quite expensively with a Price/Earnings ratio of 68.28.
The rest of the industry has a similar Price/Earnings ratio as 1ISRG.
The average S&P500 Price/Earnings ratio is at 27.19. 1ISRG is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 59.39, 1ISRG can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than the industry average as 70.77% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.88, 1ISRG is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.28 | ||
| Fwd PE | 59.39 |
4.2 Price Multiples
1ISRG's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 66.15% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as 1ISRG.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 92.72 | ||
| EV/EBITDA | 58.62 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of 1ISRG may justify a higher PE ratio.
1ISRG's earnings are expected to grow with 15.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.43
PEG (5Y)5.95
EPS Next 2Y16.17%
EPS Next 3Y15.85%
5. Dividend
5.1 Amount
1ISRG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BIT:1ISRG (1/8/2026, 7:00:00 PM)
503.2
+16.55 (+3.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.29%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap178.38B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts77
Price Target509.06 (1.16%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)1.55%
PT rev (3m)2.26%
EPS NQ rev (1m)3.15%
EPS NQ rev (3m)3.5%
EPS NY rev (1m)5.63%
EPS NY rev (3m)9.92%
Revenue NQ rev (1m)1.61%
Revenue NQ rev (3m)1.8%
Revenue NY rev (1m)1.17%
Revenue NY rev (3m)2.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 68.28 | ||
| Fwd PE | 59.39 | ||
| P/S | 21.91 | ||
| P/FCF | 92.72 | ||
| P/OCF | 71.13 | ||
| P/B | 12.36 | ||
| P/tB | 12.62 | ||
| EV/EBITDA | 58.62 |
EPS(TTM)7.37
EY1.46%
EPS(NY)8.47
Fwd EY1.68%
FCF(TTM)5.43
FCFY1.08%
OCF(TTM)7.07
OCFY1.41%
SpS22.97
BVpS40.72
TBVpS39.89
PEG (NY)3.43
PEG (5Y)5.95
Graham Number82.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 12.45% | ||
| ROICexc | 24.65% | ||
| ROICexgc | 25.69% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC9.81%
ROIC/WACC1.27
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.46%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / 1ISRG.MI FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 6 / 10 to 1ISRG.MI.
What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?
ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for 1ISRG stock?
The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 68.28 and the Price/Book (PB) ratio is 12.36.
Can you provide the financial health for 1ISRG stock?
The financial health rating of INTUITIVE SURGICAL INC (1ISRG.MI) is 7 / 10.